)
Edge12 Dec 2025
Running on Clouds: The Story of On
The story of how a Swiss runner's pursuit of a new running sensation became On, aiming to be the most premium global sportswear brand worldwide.
Insulet
Insulet (PODD) investor relations material
Insulet 44th Annual J.P. Morgan Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.44th Annual J.P. Morgan Healthcare Conference summary13 Jan, 2026
Vision and Market Opportunity
Aims to reduce the daily burden of diabetes globally through empathetic, science-driven innovation, transforming lives through technology.
Total addressable market exceeds $30 billion, with ambitions to double reach from 8 million to 17 million people globally.
Holds the top position in U.S. and EU for new customer starts and prescribed AID systems, with over 600,000 active customers across 25 global markets.
U.S. and international markets for Type 1 and Type 2 diabetes remain under-penetrated, offering significant growth runway.
Automated insulin delivery (AID) penetration lags behind CGM, highlighting a large opportunity for expansion.
Competitive Advantages and Financial Performance
Maintains deep competitive moats in technology, manufacturing scale, brand loyalty, and access model.
Achieved 26% CAGR over five years, with 25% CAGR from 2021–2025, expanding operating margins by nearly 600 basis points.
Free cash flow positive since 2023, increasing by $510M from 2021–2025, supporting ongoing investment.
Forecasts 20% revenue growth and 25%+ adjusted EPS CAGR through 2028, with margin expansion and strong free cash flow.
2025 revenue guidance projects 28–29% constant currency growth, with international Omnipod growth outpacing U.S.
Innovation Pipeline and Product Development
Investing $1 billion in R&D over the next three years to advance Omnipod 6 and fully closed loop systems.
Omnipod 5 is the most requested and prescribed AID system, with over 600,000 users in 25 markets.
Omnipod 5 ecosystem enhancements in 2026 include improved algorithms, full CGM integration, and streamlined onboarding.
Omnipod 6, launching in 2027, aims to set new standards in wearable AID with better connectivity and user experience.
Fully closed loop system for Type 2 diabetes targets 2028 launch, designed for ease of use and minimal patient burden.
Sustain competitive moats vs new patch pumps
T2D fully closed loop: primary care strategy
Omnipod 6 single SKU impact on cost & innovation
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Insulet earnings date
Q4 202518 Feb, 2026
Insulet
Next Insulet earnings date
Q4 202518 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Insulet Corporation is a medical device company that develops and manufactures tubeless insulin pump systems for people with diabetes. Its flagship product is a wearable device that delivers continuous subcutaneous insulin infusion. The company markets its technology directly and through partnerships with healthcare providers. Insulet Corporation is headquartered in Acton, Massachusetts, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage